Cargando...
Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)
BACKGROUND: The use of imatinib mesylate is associated with a progression free survival of 41 months in first line treatment of metastatic or locally advanced gastrointestinal stromal tumors (GIST) and other studies approved that adjuvant imatinib treatment improves the recurrence-free survival in p...
Gardado en:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2012
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3404905/ https://ncbi.nlm.nih.gov/pubmed/22612794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-186 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|